Register for real-time alerts, custom portfolio, and market movers

Get Started

REGN Regeneron Pharmaceuticals Inc

894.14

0.15 (0.02%)

Last Updated: 11:18:54

Delayed by 15 minutes

Regeneron's Eylea reduces vision loss by 68% after two years in diabetic retinopathy

To read the full story on Seeking Alpha, click here.

Regeneron Pharmaceuticals (NASDAQ:REGN)
Historical Stock Chart
From Mar 2024 to Apr 2024

Click Here for more Regeneron Pharmaceuticals Charts.

Regeneron Pharmaceuticals (NASDAQ:REGN)
Historical Stock Chart
From Apr 2023 to Apr 2024

Click Here for more Regeneron Pharmaceuticals Charts.

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Share on Facebook Share on Twitter Share on Email

Loading Messages....

See More Message Board Posts

Regeneron Pharmaceuticals Inc News

More Regeneron Pharmaceuticals Inc News Articles

FuelCell Energy

Federal Home Loan Mortgage (QB)

Nexus Energy Services (PK)

Anavex Life Sciences

Seafarer Exploration (PK)

Bell Buckle (PK)

Strategic Asset Leasing (PK)

Therapeutic Solutions (PK)

Decentral Life (PK)

Globestar Therapeutics (PK)

Delayed Upgrade Clock